SEC Form 4 · accession 0001140361-17-043629
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hollingshead
Officer — President, Sleep Business
Period of report
Nov 20, 2017
Accepted (ET)
Nov 22, 2017 · 10:48 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Nov 20, 2017 | M | 7,019 | $43.63 | A | 66,409 | D | |
| ResMed Common StockF1 | Nov 20, 2017 | S | 7,019 | $84.16 | D | 59,390 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $43.63 | Nov 20, 2017 | M | 7,019 | D | Mar 1, 2014 | Mar 1, 2020 | ResMed Commmon Stock | 7,019 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $83.74 to $84.53. The price reported above reflects the weighted average sale price.
- F2Represents date options first become exercisable. Options vest 1/3 annually each November 11.